Lead Product(s) : Bifidobacterium Breve
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Biohm Health, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 14, 2022
Lead Product(s) : Bifidobacterium Breve
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Biohm Health, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bifidobacterium Breve
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : KGK Science
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
December 21, 2020
Lead Product(s) : Bifidobacterium Breve
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : KGK Science
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bifidobacterium Breve
Therapeutic Area : Pediatrics
Study Phase : Phase II
Sponsor : European Regional Development Fund | Ministry of Science and Innovation, Spain
Deal Size : Inapplicable
Deal Type : Inapplicable
Infant Colic Treatment With Probiotics
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 16, 2018
Lead Product(s) : Bifidobacterium Breve
Therapeutic Area : Pediatrics
Highest Development Status : Phase II
Sponsor : European Regional Development Fund | Ministry of Science and Innovation, Spain
Deal Size : Inapplicable
Deal Type : Inapplicable